Blueprint Medicines patents new CDK4 degradation inducers

BioPharma DiveSensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy

Endpoints NewsSummit withdraws $500M offering, citing 'market conditions'

Clinical OMICsLipid-Protein Biomarker Makes Clinical Debut with Early Ovarian Cancer Detection

Endpoints NewsSensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophy

Endpoints NewsCamurus’ second CRL for acromegaly drug; Teva details workforce cuts

FierceBiotechFierce Biotech heading to UK to host event amid London Life Sciences Week

Endpoints NewsBiopharma pay report: Top-paid CSOs, CMOs of 2025

Endpoints NewsKardigan plans $320M IPO for heart drugs as Nasdaq listings gain steam

PharmaVoiceCompetition is brewing between ADCs and bispecifics

BioWorldInnovo Therapeutics synthesizes new NMT1 inhibitors

BioWorldShanghai Qingrun Pharmaceutical Technology patents new Mat2A inhibitors

BioWorldSalubris Pharma reports new RXFP1 receptor agonists